THU0203 Baricitinib Targets The Type I IFN/STAT-Medicated Activities of Human T Cells and Dendritic Cells

S. Kubo; S. Nakayamada; K. Nakano; Y. Tanaka

doi:10.1136/annrheumdis-2016-eular.2222

Article info

Poster Presentations

Rheumatoid arthritis - non-biologic treatment and small molecules

THU0203 Baricitinib Targets The Type I IFN/STAT-Medicated Activities of Human T Cells and Dendritic Cells

Authors

S. Kubo The First Department of Internal Medicine, University of Occupational and Environmental Health, Fukuoka, Japan PubMed articles Google scholar articles
S. Nakayamada The First Department of Internal Medicine, University of Occupational and Environmental Health, Fukuoka, Japan PubMed articles Google scholar articles
K. Nakano The First Department of Internal Medicine, University of Occupational and Environmental Health, Fukuoka, Japan PubMed articles Google scholar articles
Y. Tanaka The First Department of Internal Medicine, University of Occupational and Environmental Health, Fukuoka, Japan PubMed articles Google scholar articles

Citation

Kubo S, Nakayamada S, Nakano K, et al

THU0203 Baricitinib Targets The Type I IFN/STAT-Medicated Activities of Human T Cells and Dendritic Cells

Annals of the Rheumatic Diseases 2016;75:260.

Publication history

First published July 15, 2016.

Online issue publication

February 18, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password